Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BPTU (BMS-646786) is an allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contraction of rat and mouse colon induced by electrical field stimulation, nicotine and P2Y agonists. Antithrombotic; reduces platelet aggregation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 32.00 | |
2 mg | In stock | $ 45.00 | |
5 mg | In stock | $ 66.00 | |
10 mg | In stock | $ 118.00 | |
25 mg | In stock | $ 251.00 | |
50 mg | In stock | $ 433.00 | |
100 mg | In stock | $ 642.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 66.00 |
Description | BPTU (BMS-646786) is an allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contraction of rat and mouse colon induced by electrical field stimulation, nicotine and P2Y agonists. Antithrombotic; reduces platelet aggregation. |
Targets&IC50 | P2Y1:0.06-0.3 μM(EC50) |
In vivo | Octreotide-treated groups show a significant reduction in the tumor volume when compared with saline group. Octreotide-PPSG (1.4 mg/kg, i.p.) shows greater antitumor effect than Octreotide-soln (100 μg/kg, i.p.). Octreotide-treatments results in significant inhibitory effect on the expression levels of SSTR2 and SSTR5 in primary HCC-bearing rats compared with the saline group. Octreotide-PPSG appears to inhibit the expression of SSTR2 and SSTR5 to a greater extent than that of Octreotide-soln treated group. A test dose of octreotide acetate significantly decreases the serum gastrin level to approximately one third of the baseline in 2 hr and the effect lasted approximately for 6 hr. On day 21, treatment with sustained-release formulation of octreotide acetatea (5 mg intramuscular, q 4 wk) is initiated. |
Synonyms | BMS-646786 |
Molecular Weight | 445.43 |
Formula | C23H22F3N3O3 |
CAS No. | 870544-59-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BPTU 870544-59-5 GPCR/G Protein Neuroscience P2Y Receptor antithrombotic thrombosis BMS-646786 BMS646786 inhibit BMS 646786 Inhibitor inhibitor